{"id":"https://openalex.org/W2578989554","doi":"https://doi.org/10.1182/blood.v124.21.1584.1584","title":"A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy","display_name":"A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2578989554","doi":"https://doi.org/10.1182/blood.v124.21.1584.1584","mag":"2578989554"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.1584.1584","doi":"https://doi.org/10.1182/blood.v124.21.1584.1584","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.1584.1584","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Glaspy","raw_affiliation_strings":["UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084401978","display_name":"Tom Tang","orcid":"https://orcid.org/0000-0002-9085-8822","observed_orcids":["https://orcid.org/0000-0002-9085-8822","https://orcid.org/0000-0003-2589-703X"]},"institutions":[{"id":"https://openalex.org/I4210118639","display_name":"Evive Biotech (China)","ror":"https://ror.org/02f6hqb19","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210118639"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tom Tang","raw_affiliation_strings":["Generon (Shanghai) Corporation Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Generon (Shanghai) Corporation Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4210118639"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061962090","display_name":"Dean Rutty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dean Rutty","raw_affiliation_strings":["Everest Clinical Research Inc., Markham, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Everest Clinical Research Inc., Markham, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101651076","display_name":"Xiaoqiang Yan","orcid":"https://orcid.org/0000-0002-2473-3124","observed_orcids":["https://orcid.org/0000-0002-2473-3124"]},"institutions":[{"id":"https://openalex.org/I4210118639","display_name":"Evive Biotech (China)","ror":"https://ror.org/02f6hqb19","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210118639"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoqiang Yan","raw_affiliation_strings":["Generon Corporation Ltd, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Generon Corporation Ltd, Shanghai, China","institution_ids":["https://openalex.org/I4210118639"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019547742","display_name":"Igor Bondarenko","orcid":"https://orcid.org/0000-0002-7071-2471","observed_orcids":["https://orcid.org/0000-0002-7071-2471"]},"institutions":[{"id":"https://openalex.org/I905458539","display_name":"Dnipro State Medical University","ror":"https://ror.org/0469ncz24","country_code":"UA","type":"healthcare","lineage":["https://openalex.org/I905458539"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Igor Bondarenko","raw_affiliation_strings":["Dnepropetrovsk Medical Academy, Dnepropetrovsk, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dnepropetrovsk Medical Academy, Dnepropetrovsk, Ukraine","institution_ids":["https://openalex.org/I905458539"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048741591","display_name":"D A Krasnozhon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dmitrii Krasnozhon","raw_affiliation_strings":["GBUZ LOOD Surgery department-Oncologist, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GBUZ LOOD Surgery department-Oncologist, Saint Petersburg, Russia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.322,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.65372082,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"124","issue":"21","first_page":"1584","last_page":"1584"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.8220000267028809},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8230000138282776},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7440000176429749},{"id":"https://openalex.org/keywords/docetaxel-cyclophosphamide","display_name":"docetaxel-cyclophosphamide","score":0.7680000066757202},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.6140000224113464},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4169999957084656},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C2778658803","wikidata":"https://www.wikidata.org/wiki/Q1592932","display_name":"Pegfilgrastim","level":5,"score":0.9102879762649536},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8145732879638672},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7804819941520691},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6975654363632202},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6624683737754822},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6112663745880127},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5683004856109619},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5600435137748718},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5453301668167114},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.5237300992012024},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4703391194343567},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4040290415287018},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37201982736587524},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3525657057762146},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2852029800415039}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.1584.1584","doi":"https://doi.org/10.1182/blood.v124.21.1584.1584","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.1584.1584","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2551020564","https://openalex.org/W4300649983","https://openalex.org/W1972469059","https://openalex.org/W4220982811","https://openalex.org/W2199775161","https://openalex.org/W4248259434","https://openalex.org/W324244878","https://openalex.org/W3217597285","https://openalex.org/W1995429954","https://openalex.org/W4390781785"],"abstract_inverted_index":{"Abstract":[0,364],"Neutropenia":[1],"is":[2,16,108],"common":[3],"in":[4,115,208,213,227,252,260,264,357],"patients":[5,94,125,149,177,254,318,359],"receiving":[6,266],"myelotoxic":[7],"chemotherapy.":[8,363],"Benefilgrastim,":[9],"an":[10],"rhG-CSF":[11],"dimer":[12],"(rhG-CSF-FC":[13],"fusion":[14],"protein),":[15],"a":[17,82,145,173,304,346],"once-per-cycle":[18],"therapy":[19],"for":[20,40,136,351],"prophylactic":[21],"neutrophil":[22,315],"support.":[23],"In":[24,168,302],"this":[25],"Phase":[26],"II":[27],"trial,":[28],"230":[29],"women":[30],"with":[31,44,52,255,320],"stage":[32],"I-IV":[33],"breast":[34],"cancer":[35,358],"are":[36,90,211],"to":[37,63,232,317,335],"be":[38,61],"treated":[39,319],"4":[41,156,202,225,261,453,527],"chemotherapy":[42,77,116,128,143,171,326,341],"cycles":[43],"either":[45,65],"docetaxel/cyclophosphamide":[46],"(TC)":[47],"or":[48,67,164,191,311],"doxorubicin/docetaxel/cyclophosphamide":[49],"(TAC)":[50],"chemotherapy,":[51],"each":[53,79],"cycle":[54,117,129,209],"lasting":[55],"approximately":[56],"21":[57],"days.":[58],"Patients":[59],"will":[60],"randomized":[62,151,179],"receive":[64],"benefilgrastim":[66,88,163,190,240,309,332,350],"pegfilgrastim":[68,242,338],"(Neulasta;":[69],"6":[70,165,192,253,376,381],"mg":[71,166,193,377,382],"fixed":[72],"dose)":[73],"one":[74],"day":[75],"after":[76],"during":[78,339],"cycle,":[80],"as":[81],"subcutaneous":[83,306],"injection.":[84],"Dose":[85],"levels":[86],"of":[87,111,120,147,175,197,220,239,247,277,308,331,337,349,354],"examined":[89],"80":[91,384],"\u00b5g/kg":[92,100,162,189,313,385,388,391,394,397],"(TC":[93,101],"only),":[95],"and":[96,98,102,132,160,187,200,204,223,241,290,299,324],"240":[97,310,387,393],"320":[99,161,188,312,390,396],"TAC":[103,170,229,281,325,372],"patients).":[104],"The":[105,195,236,268,292,328,343],"primary":[106],"endpoint":[107],"the":[109,141,169,228,233,256,322,352],"duration":[110],"grade":[112,198,201,221,224],"3/4":[113,199,222,400],"neutropenia":[114,203,226,356,401,454],"1.":[118,215],"As":[119],"August":[121],"1,":[122],"2014,":[123],"232":[124],"have":[126],"completed":[127],"1;":[130],"safety":[131,237,329],"efficacy":[133],"were":[134,150,178,217,243,250,294],"analyzed":[135],"these":[137],"enrolled":[138],"patients.":[139],"For":[140],"TC":[142,234,279,323,370],"regimen,":[144,172],"total":[146,174,246,278],"141":[148],"(ratio":[152,180],"=":[153,181],"1:1:1:1)":[154],"into":[155,183],"arms":[157,185],"(80,":[158],"240,":[159],"pegfilgrastim).":[167,194],"91":[176],"1:1:1)":[182],"3":[184,519],"(240":[186],"incidence":[196],"their":[205],"mean":[206],"durations":[207],"1":[210,512,514,522],"provided":[212,314],"Table":[214,366],"There":[216],"higher":[218],"incidences":[219],"regimen":[230],"compared":[231],"regimen.":[235],"profiles":[238],"similar.":[244],"A":[245],"10":[248],"SAEs":[249,259,505,509],"reported":[251],"majority":[257],"(7":[258],"patients)":[262,282],"occurring":[263],"those":[265],"pegfilgrastim.":[267],"most":[269],"commonly":[270],"observed":[271],"treatment":[272,297,300],"emergent":[273],"adverse":[274,531],"events":[275],"(>10%":[276],"+":[280],"were:":[283],"alopecia,":[284],"nausea,":[285],"asthenia,":[286],"neutropenia,":[287],"bone":[288],"pain,":[289],"fatigue.":[291],"rates":[293],"similar":[295],"amongst":[296],"regimens":[298],"groups.":[301],"summary,":[303],"single":[305],"injection":[307],"support":[316],"both":[321],"regimens.":[327],"profile":[330],"was":[333],"comparable":[334],"that":[336],"multiple":[340],"cycles.":[342],"results":[344],"suggest":[345],"potential":[347],"use":[348],"management":[353],"severe":[355],"undergoing":[360],"high":[361],"dose":[362],"1584.":[365],"1:":[367],"Preliminary":[368],"Results":[369],"Regimen":[371,373],"Benefilgrastim":[374,379],"Pegfilgrastim":[375,380],"(N=35)":[378,386],"(N=29)":[383,395],"(N=37)":[389],"(N=34)":[392],"(N=30)":[398],"Grade":[399,452],"n/N":[402,455],"(%)":[403,456,507],"10/35":[404],"(28.6)":[405],"10/37":[406],"(27.0)":[407],"7/34":[408],"(20.6)":[409],"7/35":[410],"(20.0)":[411],"17/25":[412],"(68.0)":[413],"19/26":[414],"(73.1)":[415],"17/24":[416],"(70.8)":[417],"Duration":[418,471],"(days)":[419,472],"Mean":[420,473],"(SD)":[421,474],"95%":[422,475],"CI":[423,476],"2.4":[424,500],"(2.07)":[425],"1.2,":[426,503],"3.6":[427],"2.2":[428,448],"(0.79)":[429,437],"1.7,":[430],"2.7":[431],"1.9":[432,493],"(0.38)":[433],"1.6,":[434,499],"2.1":[435,481],"1.4":[436],"0.9,":[438],"2.0":[439,477,497],"2.8":[440,484],"(1.67)":[441],"2.1,":[442],"3.5":[443],"2.6":[444,496],"(1.07)":[445],"2.2,":[446],"3.1":[447],"(0.73)":[449],"1.9,":[450],"2.5":[451],"4/35":[457],"(11.4)":[458],"7/37":[459],"(18.9)":[460],"6/34":[461],"(17.6)":[462],"3/35":[463],"(8.6)":[464],"14/25":[465],"(56.0)":[466],"17/26":[467],"(65.4)":[468],"15/24":[469],"(62.5)":[470],"(1.15)":[478],"0.6,":[479],"3.4":[480],"(0.90)":[482],"1.5,":[483],"1.2":[485],"(0.41)":[486],"0.8,":[487],"1.5":[488,501],"1.0":[489,492],"(0.00)":[490],"1.0,":[491],"(1.33)":[494],"1.3,":[495],"(0.87)":[498],"(0.64)":[502],"1.8":[504],"n":[506],"#":[508],"0":[510,511,515,516,520,521],"(2.7)":[513],"2":[517,524,525],"(5.7)":[518],"(3.3)":[523],"(6.9)":[526],"CI=confidence":[528],"interval;":[529],"SAE=serious":[530],"event;":[532],"SD=standard":[533],"deviation":[534],"Disclosures":[535],"Glaspy:":[536],"Generon":[537,554],"(Shanghai)":[538,544,555,603],"Corporation":[539,545,556,604],"Ltd.:":[540,546,557,605],"Research":[541,550,571],"Funding.":[542],"Tang:Generon":[543],"Employment.":[547,606],"Rutty:Everest":[548],"Clinical":[549],"Services":[551],"Inc.:":[552],"Employment;":[553],"Consultancy;":[558,561,563,565,569,574,578,580,583,590,593,596],"Schering":[559],"Corporation:":[560],"Roche:":[562],"Methylgene:":[564],"Steba":[566],"Biotech":[567],"SA:":[568],"Aderans":[570],"Institute":[572],"Inc:":[573,592],"Stem":[575],"Cell":[576],"Theraputics:":[577],"Genentech:":[579],"Pearly":[581],"Therapeutics:":[582],"Sundise":[584],"Chinese":[585],"Medicine":[586],"Technology":[587],"Development":[588],"Corp:":[589],"Endocyte,":[591],"Hutchison":[594],"Medipharma:":[595],"Nutrition":[597],"Science":[598],"Partners":[599],"Limited:":[600],"Consultancy.":[601],"Yan:Generon":[602]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-01-26T00:00:00"}